Document

Learn why nonviral vectors are on the rise in gene therapy development.

New technologies are allowing researchers to delve deeper into the complex tumor landscape.

Researchers can achieve seamless western blot experiments by implementing advancements in stain-free technology, normalization methods, and compliance integration. 

Proteomics-guided biomarker discovery unlocks new pathways to understanding, diagnosing, and treating diseases. 

Spatial biology adds a new layer of knowledge to unsolved biological questions.

Computational methods add new options for teasing apart cellular heterogeneity.

Emerging gene editing approaches pave the way for safer, more successful transplants.

Detecting tumor antigens is key to developing effective cancer diagnostics, immunotherapies, and vaccines.

Cell-free gene synthesis technology offers a quick, reliable route to creating vital mRNA vaccines and therapeutics. 

Spatial transcriptomics technologies unveil a goldmine of biological information.

Biobanking gives scientists access to thousands of biological samples, moving precision medicine one step closer to reality.

Many of the same therapies used to activate the immune system against cancer may also combat infectious diseases.

Antimicrobial resistance poses a significant threat to healthcare. Ultra-microscopic viruses called bacteriophages might hold a solution.

Highly potent antibody candidates isolated via advanced flow cytometry is growing the list of approved therapeutic antibodies.

How do scientists delve into the spatial dimensions of cancer biology to make new discoveries?  

The blood-brain barrier seems impenetrable, but new therapeutic antibodies may creep past its defenses. 

Some infectious diseases require unique modifications to the traditional vaccine development approach.  

By directly and precisely destroying troublesome proteins, PROTAC molecules emerge as effective tools for enhancing cancer treatment.

Different precision medicine approaches modulate distinct pathways to treat cancer, but how do scientists know which approach is best?

A collaborative team overcomes the long-standing challenge of blurred imaging, illuminating once hidden details within the depths of thick samples.